Brief: Sight Sciences announces long-term safety and effectiveness data of standalone use of the Omni® surgical system in patients with open angle glaucoma
16/08/2022 13:20
Aug 16 (Reuters) - Sight Sciences Inc SGHT.O :
* SIGHT SCIENCES ANNOUNCES LONG-TERM SAFETY AND
EFFECTIVENESS DATA
OF STANDALONE USE OF THE OMNI® SURGICAL SYSTEM IN PATIENTS WITH
OPEN ANGLE GLAUCOMA
* SIGHT SCIENCES-DATA SHOWS OMNI SURGICAL SYSTEM DELIVERS
SAFE,CONSISTENT,DURABLE RESULTS IN ADULT PATIENTS WITH
OPEN-ANGLE GLAUCOMA ON STANDALONE BASIS
Source text for Eikon: ID:nGNX23jfV9
Further company coverage: SGHT.O
Recent news on Sight Sciences
See all newsSight Sciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Sight Sciences Q2 revenue rises 20%, beats estimates
Brief: Sight Sciences Q2 Revenue USD 23.4 Million Vs. IBES Estimate USD 21.7 Million
Sight Sciences, Inc. expected to post a loss of 15 cents a share - Earnings Preview
Sight Sciences raises FY 2026 revenue outlook